Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models
ACS Chemical Biology · 2025
DOI: 10.1021/acschembio.4c00870 ↗At a glance
Journal article in ACS Chemical Biology, 2025. Written by Suresh Awale and 9 co-authors. Institution: Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. Major MEDLINE topics: Pancreatic Neoplasms, Antineoplastic Agents, Alkaloids, Isoquinolines. Cited 2 times so far (Crossref); 45 references. Funded by: Deutsche Forschungsgemeinschaft, Japan Society for the Promotion of Science, University of Toyama.
Abstract (original language)
Pancreatic cancer is a highly aggressive and lethal malignancy, with a 5-year survival rate below 10%. Traditional chemotherapy, including gemcitabine, has limited efficacy due to chemoresistance and a unique tumor microenvironment characterized by hypovascularity and nutrient deprivation. This study reports on the discovery of a new N-biphenyl-dihydroisoquinoline, named toyaburgine (4), inspired by naturally occurring N,C-coupled naphthylisoquinoline alkaloids. Developed through systematic structural optimization, toyaburgine is a potent anticancer agent, showing promise for pancreatic cancer treatment. It exhibits strong antiausterity activity with low nanomolar PC50 values, effectively inhibiting pancreatic cancer cell viability under nutrient-deprived conditions. In vitro, 4 causes significant morphological changes and cancer cell death in MIA PaCa-2 cells while also inhibiting cell migration and colony formation, which indicates its antimetastatic potential. Mechanistically, toyaburgine disrupts the PI3K/Akt/mTOR pathway, essential for pancreatic cancer cell survival in a stressful microenvironment, and inhibits MIA PaCa-2 spheroid formation. In vivo, toyaburgine, alone or combined with gemcitabine, shows effective tumor suppression in subcutaneous xenograft and clinically relevant orthotopic models, where it also reduces cachexia. These results highlight the potential of toyaburgine as a new therapeutic drug for pancreatic cancer. Its combination with gemcitabine presents a promising treatment approach by targeting both proliferating and gemcitabine-resistant cancer cells.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
- Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
- Department of Chemistry-Biology, and Center of Micro- and Nanochemistry and (Bio)Technology (Cμ), University of Siegen, Adolf-Reichwein-Straße 2, 57068 Siegen, Germany.
- Department of Chemistry, Ahmadu Bello University, 810107 Zaria, Nigeria.
- Institute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
ORCID profiles: Suresh Awale, Hung Hong Nguyen, Tsutomu Fujii, Heiko Ihmels, Gerhard Bringmann
Funding
- Deutsche Forschungsgemeinschaft
- Japan Society for the Promotion of Science
- University of Toyama
Cite
APA
Awale, S., Maneenet, J., Phan, N. D., Nguyen, H. H., Fujii, T., Ihmels, H., Soost, D., Tajuddeen, N., Feineis, D., & Bringmann, G. (2025). Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00870
Vancouver
Awale S, Maneenet J, Phan ND, Nguyen HH, Fujii T, Ihmels H, et al. Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models. ACS Chemical Biology. 2025. doi:10.1021/acschembio.4c00870
BibTeX
@article{Awale2025,
author = {Awale, Suresh and Maneenet, Juthamart and Phan, Nguyen Duy and Nguyen, Hung Hong and Fujii, Tsutomu and Ihmels, Heiko and Soost, Denisa and Tajuddeen, Nasir and Feineis, Doris and Bringmann, Gerhard},
title = {Toyaburgine, a Synthetic N -Biphenyl-Dihydroisoquinoline Inspired by Related N , C -Coupled Naphthylisoquinoline Alkaloids, with High In Vivo Efficacy in Preclinical Pancreatic Cancer Models},
journal = {ACS Chemical Biology},
year = {2025},
doi = {10.1021/acschembio.4c00870}
}
EUVIMED